procainamide hydrochloride · Apothecon · NDA 007335, 017371

Pronestyl

Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 8

NDA · productFormStrengthListed expiry
007335 · 001 · RLD · discontinuedcapsule, oral250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
007335 · 002 · RLD · discontinuedinjectable, injection100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
007335 · 003 · RLD · discontinuedcapsule, oral500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
007335 · 004 · RLD · discontinuedcapsule, oral375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
007335 · 005 · RLD · discontinuedinjectable, injection500MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
017371 · 001 · discontinuedtablet, oral250MGopen
017371 · 002 · discontinuedtablet, oral375MGopen
017371 · 003 · discontinuedtablet, oral500MGopen